| Regulating gene transcription in response to cyclic AMP elevation WA Sands, TM Palmer Cellular signalling 20 (3), 460-466, 2008 | 409 | 2008 |
| Adenosine receptors TM Palmer, GL Stiles Neuropharmacology 34 (7), 683-694, 1995 | 398 | 1995 |
| Canagliflozin inhibits interleukin-1β-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and-independent mechanisms SJ Mancini, D Boyd, OJ Katwan, A Strembitska, TA Almabrouk, ... Scientific reports 8 (1), 5276, 2018 | 241 | 2018 |
| Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells WA Sands, HD Woolson, GR Milne, C Rutherford, TM Palmer Molecular and cellular biology 26 (17), 6333-6346, 2006 | 191 | 2006 |
| Tethering of the platelet-derived growth factor β receptor to G-protein-coupled receptors: a novel platform for integrative signaling by these receptor classes in mammalian cells F Alderton, S Rakhit, KC Kong, T Palmer, B Sambi, S Pyne, NJ Pyne Journal of Biological Chemistry 276 (30), 28578-28585, 2001 | 188 | 2001 |
| Differential interaction with and regulation of multiple G-proteins by the rat A3 adenosine receptor TM Palmer, TW Gettys, GL Stiles Journal of Biological Chemistry 270 (28), 16895-16902, 1995 | 179 | 1995 |
| Targeting SOCS proteins to control JAK-STAT signalling in disease GA Durham, JJL Williams, MT Nasim, TM Palmer Trends in pharmacological sciences 40 (5), 298-308, 2019 | 158 | 2019 |
| Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation IP Salt, TM Palmer Expert opinion on investigational drugs 21 (8), 1155-1167, 2012 | 156 | 2012 |
| Anti‐Inflammatory and Immunosuppressive Effects of the A2A Adenosine Receptor GR Milne, TM Palmer The Scientific World Journal 11 (1), 320-339, 2011 | 150 | 2011 |
| Identification of threonine residues controlling the agonist-dependent phosphorylation and desensitization of the rat A3 adenosine receptor TM Palmer, GL Stiles Molecular pharmacology 57 (3), 539-545, 2000 | 130 | 2000 |
| Agonist-dependent phosphorylation and desensitization of the rat A3 adenosine receptor: evidence for a G-protein-coupled receptor kinase-mediated mechanism TM Palmer, JL Benovic, GL Stiles Journal of Biological Chemistry 270 (49), 29607-29613, 1995 | 119 | 1995 |
| 125I-4-(2-[7-amino-2-[2-furyl][1, 2, 4] triazolo [2, 3-a][1, 3, 5] triazin-5-yl-amino] ethyl) phenol, a high affinity antagonist radioligand selective for the A2a adenosine … TM Palmer, SM Poucher, KA Jacobson, GL Stiles Molecular pharmacology 48 (6), 970-974, 1995 | 119 | 1995 |
| Identification of myeloid cells in the human enthesis as the main source of local IL-23 production C Bridgewood, A Watad, T Russell, TM Palmer, H Marzo-Ortega, A Khan, ... Annals of the rheumatic diseases 78 (7), 929-933, 2019 | 112 | 2019 |
| Regulation of cell survival by sphingosine-1-phosphate receptor S1P1 via reciprocal ERK-dependent suppression of Bim and PI-3-kinase/protein kinase C-mediated upregulation of Mcl-1 C Rutherford, S Childs, J Ohotski, L McGlynn, M Riddick, S MacFarlane, ... Cell death & disease 4 (11), e927-e927, 2013 | 111 | 2013 |
| Activation of AMP-activated protein kinase rapidly suppresses multiple pro-inflammatory pathways in adipocytes including IL-1 receptor-associated kinase-4 phosphorylation SJ Mancini, AD White, S Bijland, C Rutherford, D Graham, EA Richter, ... Molecular and cellular endocrinology 440, 44-56, 2017 | 108 | 2017 |
| Dual regulation of EDG1/S1P1 receptor phosphorylation and internalization by protein kinase C and G-protein-coupled receptor kinase 2 KR Watterson, E Johnston, C Chalmers, A Pronin, SJ Cook, JL Benovic, ... Journal of Biological Chemistry 277 (8), 5767-5777, 2002 | 104 | 2002 |
| Phosphorylation of Janus kinase 1 (JAK1) by AMP-activated protein kinase (AMPK) links energy sensing to anti-inflammatory signaling C Rutherford, C Speirs, JJL Williams, MA Ewart, SJ Mancini, SA Hawley, ... Science signaling 9 (453), ra109-ra109, 2016 | 102 | 2016 |
| Molecular basis for subtype-specific desensitization of inhibitory adenosine receptors: Analysis of a chimeric A1-A3 adenosine receptor TM Palmer, JL Benovic, GL Stiles Journal of Biological Chemistry 271 (25), 15272-15278, 1996 | 98 | 1996 |
| Suppression of inflammatory and immune responses by the A2A adenosine receptor: an introduction TM Palmer, MA Trevethick British journal of pharmacology 153 (S1), S27-S34, 2008 | 97 | 2008 |
| Desensitization of the canine A2a adenosine receptor: delineation of multiple processes. TM Palmer, TW Gettys, KA Jacobson, GL Stiles Molecular pharmacology 45 (6), 1082-1094, 1994 | 97 | 1994 |
Ian SaltReader, University of GlasgowE-mail megerősítve itt: glasgow.ac.uk